Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. This position reports to Chief Development Officer and is part of the Biopharma Clinical Research Team. The role is responsible for providing overall leadership and scientific oversight of clinical development strategies and plans for stem cell therapies, symptomatic treatments, and disease-modifying therapies in the Parkinson’s disease and movement disorders field. Accelerate the US development of DSP-1083, which is building on the success of Amchepry®, a iPS cell-based regenerative therapy developed by Sumitomo Pharma, which has received the world’s first conditional approval in Japan. The role is responsible for providing overall leadership and scientific oversight of clinical development strategies and plans for Stem Cell Therapies and CNS (Parkinson’s disease and movement disorders) pipeline assets leading to successful NDA’s, sNDA’s and label optimization from Proof of Concept (PoC) through all phases of clinical development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive